Studies on the anti-cancer mechanisms of Bortezomib by proteomic techniques
碩士 === 臺北醫學大學 === 醫學科學研究所 === 96 === The proteasome is an abundant multi-enzyme complex that provides the main roles for selective degradation of intracellular unfolding proteins in eukaryotic cells. Bortezomib (PS-341) is a proteasome inhibitor which first approved by FDA to enter clinical trails i...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2008
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/37021058183723060400 |